Skip to content

Celcuity CELC Interest coverage

Interest coverage at other companies

Gilead Sciences logo
Gilead SciencesGILD
10.3×+2.0×
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-7.1×-0.8×
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-84.7×
Tenet Healthcare logo
Tenet HealthcareTHC
4.7×+0.2×
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
49.2×+32.5×
Royalty Pharma logo
Royalty PharmaRPRX
4.7×-3.0×

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Calculated from Celcuity’s reported figures.

Based on trailing twelve months.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's interest coverage?
Celcuity (CELC) reported interest coverage of -9.3× in Q1 2026.
How has Celcuity's interest coverage changed year-over-year?
Celcuity's interest coverage increased by 11.6% year-over-year, from -10.5× to -9.3×.
What is the long-term trend for Celcuity's interest coverage?
Over 5 years (2020 to 2025), Celcuity's interest coverage has grown at a -83.4% compound annual growth rate (CAGR), from -80,303.9× to -10×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.